Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2008 2
2009 2
2012 1
2016 1
2017 2
2018 2
2020 4
2021 3
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Results by year

Filters applied: . Clear all
Page 1
GADD34 activates p53 and may have utility as a marker of atherosclerosis.
Tomiyoshi G, Nakamura R, Shinmen N, Yoshida Y, Mine S, Machida T, Iwase K, Iwadate Y, Hiwasa T, Kuroda H. Tomiyoshi G, et al. Among authors: shinmen n. Front Med (Lausanne). 2023 May 9;10:1128921. doi: 10.3389/fmed.2023.1128921. eCollection 2023. Front Med (Lausanne). 2023. PMID: 37228401 Free PMC article.
Serum anti-AP3D1 antibodies are risk factors for acute ischemic stroke related with atherosclerosis.
Li SY, Yoshida Y, Kobayashi E, Kubota M, Matsutani T, Mine S, Machida T, Maezawa Y, Takemoto M, Yokote K, Kobayashi Y, Takizawa H, Sata M, Yamagishi K, Iso H, Sawada N, Tsugane S, Kobayashi S, Matsushita K, Nomura F, Matsubara H, Sumazaki M, Ito M, Yajima S, Shimada H, Iwase K, Ashino H, Wang H, Goto K, Tomiyoshi G, Shinmen N, Nakamura R, Kuroda H, Iwadate Y, Hiwasa T. Li SY, et al. Among authors: shinmen n. Sci Rep. 2021 Jun 29;11(1):13450. doi: 10.1038/s41598-021-92786-9. Sci Rep. 2021. PMID: 34188129 Free PMC article. Clinical Trial.
Serum anti-DIDO1, anti-CPSF2, and anti-FOXJ2 antibodies as predictive risk markers for acute ischemic stroke.
Hiwasa T, Wang H, Goto KI, Mine S, Machida T, Kobayashi E, Yoshida Y, Adachi A, Matsutani T, Sata M, Yamagishi K, Iso H, Sawada N, Tsugane S, Kunimatsu M, Kamitsukasa I, Mori M, Sugimoto K, Uzawa A, Muto M, Kuwabara S, Kobayashi Y, Ohno M, Nishi E, Hattori A, Yamamoto M, Maezawa Y, Kobayashi K, Ishibashi R, Takemoto M, Yokote K, Takizawa H, Kishimoto T, Matsushita K, Kobayashi S, Nomura F, Arasawa T, Kagaya A, Maruyama T, Matsubara H, Tomiita M, Hamanaka S, Imai Y, Nakagawa T, Kato N, Terada J, Matsumura T, Katsumata Y, Naito A, Tanabe N, Sakao S, Tatsumi K, Ito M, Shiratori F, Sumazaki M, Yajima S, Shimada H, Shirouzu M, Yokoyama S, Kudo T, Doi H, Iwase K, Ashino H, Li SY, Kubota M, Tomiyoshi G, Shinmen N, Nakamura R, Kuroda H, Iwadate Y. Hiwasa T, et al. Among authors: shinmen n. BMC Med. 2021 Jun 9;19(1):131. doi: 10.1186/s12916-021-02001-9. BMC Med. 2021. PMID: 34103026 Free PMC article.
Activation of NFAT signal by p53-K120R mutant.
Shinmen N, Koshida T, Kumazawa T, Sato K, Shimada H, Matsutani T, Iwadate Y, Takiguchi M, Hiwasa T. Shinmen N, et al. FEBS Lett. 2009 Jun 18;583(12):1916-22. doi: 10.1016/j.febslet.2009.04.041. Epub 2009 May 3. FEBS Lett. 2009. PMID: 19416725 Free article.
Elevated levels of autoantibodies against DNAJC2 in sera of patients with atherosclerotic diseases.
Yoshida Y, Zhang XM, Wang H, Machida T, Mine S, Kobayashi E, Adachi A, Matsutani T, Kamitsukasa I, Wada T, Aotsuka A, Iwase K, Tomiyoshi G, Nakamura R, Shinmen N, Kuroda H, Takizawa H, Kashiwado K, Shin H, Akaogi Y, Shimada J, Nishi E, Ohno M, Takemoto M, Yokote K, Kitamura K, Iwadate Y, Hiwasa T. Yoshida Y, et al. Among authors: shinmen n. Heliyon. 2020 Aug 19;6(8):e04661. doi: 10.1016/j.heliyon.2020.e04661. eCollection 2020 Aug. Heliyon. 2020. PMID: 32904265 Free PMC article.
Serum anti-LRPAP1 is a common biomarker for digestive organ cancers and atherosclerotic diseases.
Sumazaki M, Shimada H, Ito M, Shiratori F, Kobayashi E, Yoshida Y, Adachi A, Matsutani T, Iwadate Y, Mine S, Machida T, Kamitsukasa I, Mori M, Sugimoto K, Uzawa A, Kuwabara S, Kobayashi Y, Ohno M, Nishi E, Maezawa Y, Takemoto M, Yokote K, Takizawa H, Kashiwado K, Shin H, Kishimoto T, Matsushita K, Kobayashi S, Nakamura R, Shinmen N, Kuroda H, Zhang XM, Wang H, Goto KI, Hiwasa T. Sumazaki M, et al. Among authors: shinmen n. Cancer Sci. 2020 Dec;111(12):4453-4464. doi: 10.1111/cas.14652. Epub 2020 Oct 4. Cancer Sci. 2020. PMID: 32939876 Free PMC article.
Elevation of autoantibody level against PDCD11 in patients with transient ischemic attack.
Yoshida Y, Wang H, Hiwasa T, Machida T, Kobayashi E, Mine S, Tomiyoshi G, Nakamura R, Shinmen N, Kuroda H, Takizawa H, Kashiwado K, Kamitsukasa I, Shin H, Wada T, Aotsuka A, Nishi E, Ohno M, Takemoto M, Yokote K, Takahashi S, Matsushima J, Zhang XM, Takiguchi M, Iwadate Y. Yoshida Y, et al. Among authors: shinmen n. Oncotarget. 2017 Dec 24;9(10):8836-8848. doi: 10.18632/oncotarget.23653. eCollection 2018 Feb 6. Oncotarget. 2017. PMID: 29507658 Free PMC article.
Association of serum levels of antibodies against ALDOA and FH4 with transient ischemic attack and cerebral infarction.
Wang H, Lu H, Zhang XM, Goto KI, Kobayashi E, Yoshida Y, Adachi A, Matsutani T, Iwadate Y, Mine S, Machida T, Sata M, Yamagishi K, Iso H, Sawada N, Tsugane S, Kamitsukasa I, Wada T, Aotsuka A, Sugimoto K, Takizawa H, Kashiwado K, Shin H, Tomiyoshi G, Nakamura R, Shinmen N, Kuroda H, Xu A, Hiwasa T. Wang H, et al. Among authors: shinmen n. BMC Neurol. 2021 Jul 9;21(1):274. doi: 10.1186/s12883-021-02301-w. BMC Neurol. 2021. PMID: 34243715 Free PMC article.
Circulating Anti-Sorting Nexins 16 Antibodies as an Emerging Biomarker of Coronary Artery Disease in Patients with Obstructive Sleep Apnea.
Katsumata Y, Terada J, Matsumura T, Koshikawa K, Sakao S, Tomiyoshi G, Shinmen N, Nakamura R, Kuroda H, Nagashima K, Kobayashi Y, Kobayashi E, Iwadate Y, Zhang XM, Hiwasa T, Tatsumi K. Katsumata Y, et al. Among authors: shinmen n. Diagnostics (Basel). 2020 Jan 27;10(2):71. doi: 10.3390/diagnostics10020071. Diagnostics (Basel). 2020. PMID: 32012743 Free PMC article.
Association between serum anti‑ASXL2 antibody levels and acute ischemic stroke, acute myocardial infarction, diabetes mellitus, chronic kidney disease and digestive organ cancer, and their possible association with atherosclerosis and hypertension.
Li SY, Yoshida Y, Kobayashi E, Adachi A, Hirono S, Matsutani T, Mine S, Machida T, Ohno M, Nishi E, Maezawa Y, Takemoto M, Yokote K, Kitamura K, Sumazaki M, Ito M, Shimada H, Takizawa H, Kashiwado K, Tomiyoshi G, Shinmen N, Nakamura R, Kuroda H, Zhang XM, Wang H, Goto K, Iwadate Y, Hiwasa T. Li SY, et al. Among authors: shinmen n. Int J Mol Med. 2020 Oct;46(4):1274-1288. doi: 10.3892/ijmm.2020.4690. Epub 2020 Jul 29. Int J Mol Med. 2020. PMID: 32945427 Free PMC article.
17 results